1,033 reports of this reaction
3.0% of all AMANTADINE reports
#5 most reported adverse reaction
DYSKINESIA is the #5 most commonly reported adverse reaction for AMANTADINE, manufactured by Adamas Pharma, LLC. There are 1,033 FDA adverse event reports linking AMANTADINE to DYSKINESIA. This represents approximately 3.0% of all 34,976 adverse event reports for this drug.
Patients taking AMANTADINE who experience dyskinesia should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
DYSKINESIA is a less commonly reported adverse event for AMANTADINE, but still significant enough to appear in the safety profile.
In addition to dyskinesia, the following adverse reactions have been reported for AMANTADINE:
The following drugs have also been linked to dyskinesia in FDA adverse event reports:
DYSKINESIA has been reported as an adverse event in 1,033 FDA reports for AMANTADINE. This does not prove causation, but indicates an association observed in post-market surveillance data.
DYSKINESIA accounts for approximately 3.0% of all adverse event reports for AMANTADINE, making it a notable side effect.
If you experience dyskinesia while taking AMANTADINE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.